Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

NCT03998059 ·Status: RECRUITING

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment

NCT01196884 ·Status: UNKNOWN

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

NCT01869049 ·Status: WITHDRAWN

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

NCT06408324 ·Status: COMPLETED

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

NCT07182760 ·Status: NOT_YET_RECRUITING

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

NCT03377439 ·Status: UNKNOWN

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

NCT02063763 ·Status: COMPLETED

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00454857 ·Status: COMPLETED

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829 ·Status: COMPLETED ·Phase: PHASE4

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT06665308 ·Status: COMPLETED

Study of Immune Thrombocytopenia Pathogenesis:

NCT02042560 ·Status: COMPLETED

The International ITP Registry

NCT01970189 ·Status: UNKNOWN

French Adult Primary Immune Thrombocytopenia

NCT03429660 ·Status: UNKNOWN

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

NCT02859909 ·Status: COMPLETED ·Phase: PHASE3

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

NCT03119974 ·Status: COMPLETED ·Phase: PHASE4

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296 ·Status: COMPLETED

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

NCT04735588 ·Status: UNKNOWN

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

NCT06544499 ·Status: RECRUITING ·Phase: PHASE3

Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)

NCT06594146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Switching Avatrombopag and Rh-TPO in ITP

NCT04913597 ·Status: UNKNOWN

Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura

NCT05093257 ·Status: UNKNOWN

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06107582 ·Status: RECRUITING

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075 ·Status: COMPLETED